Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=23 Randomized Treatment

Pilot Study of PDL to Treat BCC and SCCIS

Basal Cell Carcinoma · Squamous Cell Carcinoma in Situ

Bottom Line

View on ClinicalTrials.gov: NCT01245972 ↗
Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Tumor Clearance — 2; 2; 5 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PDL Treatment (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, San Diego
Primary completion
Jun 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Tumor Clearance		 2; 2; 5 —

Summary

This is a research study to find out more about the use of the pulsed dye laser in the treatment of basal cell carcinoma and early stage squamous cell carcinoma that has not invaded deep into the skin. The purpose of this study is to determine whether the use of the pulsed dye laser (PDL) can completely clear or regress basal cell carcinoma or early stage squamous cell carcinoma. Pulsed dye laser is a type of laser that is commonly used to treat lesions on the skin that have a prominent blood vessel component. It has been used to treat broken blood vessels on the face, hemangiomas in children and adults, leg veins, port wine stains, and other lesions with a prominent vascular component.

Eligibility Criteria

Inclusion Criteria

  • Patients requiring surgical excision (conventional or Mohs) for biopsy-proven basal cell carcinoma and biopsy-proven squamous cell carcinoma in situ that is clinically present at the pre-operative visit and measures greater than 0.4cm and less than 3cm in size.
  • Lesions in the Trunk, Extremities, and Scalp
  • Presence of clinically identifiable residual tumor.
  • Patients, males and females, aged 18-90 years.
  • Willing to participate.
  • Able to give informed consent.

Exclusion Criteria

  • Age younger than 18 years
  • Location of lesion not in the Trunk, Extremities, and Scalp
  • Fitzpatrick skin type V or VI.
  • Prior history of known light sensitivity.
  • Pregnancy
  • Cognitive Impairment
  • Prisoner
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01245972). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search